Tuesday 6th June 2023 |
Text too small? |
Synlait Milk Limited (Synlait) is extremely pleased to announce that the State Administration for Market Regulation (SAMR) has notified it of the successful re-registration of The a2 Milk Company’s Chinese labelled 至初® Infant Formula (stages one, two and three) at its Dunsandel facility, which will allow it to manufacture and export this product for the China market until September 2027.
As the manufacturer of those products, the SAMR registration is held by Synlait and attached to its Dunsandel facility. The re-registration is pivotal for the ongoing success of the manufacturing and supply agreement that Synlait and The a2 Milk Company have.
Synlait CEO Grant Watson commented: “We are thrilled to have achieved this significant milestone, which is pivotal to the long-term success of our Advanced Nutrition business. Our shareholders, staff, customers, and farmer suppliers all benefit from the certainty of today’s re-registration and continued China market access.”
“Synlait and The a2 Milk Company have a long-standing and complementary partnership, and we look forward to continuing to support their China growth ambitions. The re-registration is a very important milestone and we have worked hard together to ensure its success. We thank SAMR and the Ministry for Primary Industries, for their support during this process.”
No comments yet
TRU - WHO Agency UNITAID Features TRU in Tech Landscape Report
PaySauce Quarterly Market Update - September 2024
October 2nd Morning Report
Rua Releases Annual Report for Year Ended 30 June 2024
SCL - Settlement of orchard sales
The Warehouse Group 2024 ASM and Director Nominations
AIR - Update on Chief Operational Integrity and Safety Officer
Comvita Limited - Annual Report 2024
September 27th Morning Report
Spark announces departure of Finance Director